Glioma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Activation of PTGS2/NF-κB signaling pathway enhances radiation resistance of glioma.
|
30740906 |
2019 |
Glioma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Increased COX-2 expression directly correlates with glioma grade and is associated with shorter survival in glioblastoma (GBM) patients.
|
24659686 |
2014 |
Glioma
|
0.400 |
Biomarker
|
disease |
BEFREE |
This led to our interest in assessing the response of glioma cell lines to treatment with celecoxib, a selective COX-2 inhibitor.
|
21220497 |
2011 |
Glioma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Furthermore, our data show that pharmacological concentrations of celecoxib may interfere with the proapoptotic action of R(+)-MA and anandamide, suggesting that cotreatment with COX-2 inhibitors could diminish glioma regression induced by these compounds.
|
15361550 |
2004 |
Glioma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Therefore, COX-2 and survivin may be sensitive predictors of a negative clinical prognosis for patients with glioma.
|
28789345 |
2017 |
Glioma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Reprogramming COX-2, mPGES-1 and CYP4A mediated-AA metabolism in glioma by flavonoid ISL inhibits the angiogenic Akt- FGF-2/TGF-β/VEGF signaling through ceRNA effect of miR-194-5p and lncRNA NEAT1, and may serve as a novel therapeutic strategy for human glioma.
|
31438982 |
2019 |
Glioma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
In the animal experiments, IATL reduced the size and weight of glioma tumors in xenograft mice and inhibited the expression of COX-2 and phosphorylated NF-κB p65 in the transplanted tumors.
|
30740911 |
2019 |
Glioma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Further, targeting MET and Cox-2 may represent an attractive target therapy for glioma.
|
26097553 |
2015 |
Glioma
|
0.400 |
Biomarker
|
disease |
BEFREE |
All COX-2 inhibitors reduced proliferation of the glioma cell lines irrespective of their COX-2 expression level.
|
17729162 |
2007 |
Glioma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Expression analysis further revealed that Cox-2 was elevated in glioma and associated with survival of patients.
|
22406049 |
2012 |
Glioma
|
0.400 |
Biomarker
|
disease |
BEFREE |
COX-2 regulates the proliferation of glioma stem like cells.
|
21763744 |
2011 |
Glioma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Finally, treatment of glioma cell lines with prostaglandin E2, the predominant product of COX-2 activity, results in increased vascular endothelial growth factor expression, thus potentially linking elevations in COX-2 expression with tumor angiogenesis in malignant gliomas.
|
17616668 |
2007 |
Glioma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Exposure to COX-2-overexpressing glioma induced mature DCs to overexpress IL-10 and decreased IL-12p70 production.
|
15383564 |
2004 |
Glioma
|
0.400 |
Biomarker
|
disease |
BEFREE |
The Effect of Biotinylated PAMAM G3 Dendrimers Conjugated with COX-2 Inhibitor (celecoxib) and PPARγ Agonist (Fmoc-L-Leucine) on Human Normal Fibroblasts, Immortalized Keratinocytes and Glioma Cells in Vitro.
|
31652556 |
2019 |
Glioma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
A CD133(+)-enriched U87 glioma cell population, isolated from parental U87 cells with magnetic cell sorting technology, also grew as neurospheres and showed enhanced COX-2 expression.
|
19272160 |
2009 |
Glioma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
A strong negative correlation was observed between the level of miR-26b and COX-2 in 30 glioma tissues.
|
28800785 |
2019 |
Glioma
|
0.400 |
Biomarker
|
disease |
BEFREE |
The U87MG glioma cell line is a good model for COX-2 induction in glioma cell lines.
|
19029777 |
2008 |
Glioma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
In the single-locus analysis of the 23 examined SNPs, 1 pro-inflammatory and 2 anti-inflammatory gene SNPs were significantly associated with glioma risk (COX2/PTGS2, rs20417 [OR = 1.41]; IL10, rs1800896 [OR = 1.57]; and IL13, rs20541 [OR = 0.39], respectively).
|
20406895 |
2010 |
Glioma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
To determine whether the increased prostaglandin production is due to enhanced expression of PHS-2 and whether the up-regulation of PHS-2 has any correlation to histopathological findings in brain tumors, we evaluated the profile of PHS expression in several human glioma cell lines and surgical specimens from patients with various types of brain tumors.
|
11563634 |
2001 |
Glioma
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
However, the relationship between the prostaglandin-endoperoxide synthase 2 (PTGS2) genetic polymorphism and glioma remains unclear in the Chinese population.
|
25966079 |
2015 |
Glioma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
We compared effects of interferon-gamma (IFNgamma) on cyclooxygenase-2 (COX-2) expression in malignant human glioma cell lines and cultured primary human astrocytes.
|
15465602 |
2004 |
Glioma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Paraffin-embedded glioma specimens were detected for the COX-2 expression using immunohistochemistry.
|
28306608 |
2017 |
Glioma
|
0.400 |
Biomarker
|
disease |
BEFREE |
Epidermal growth factor-dependent cyclooxygenase-2 induction in gliomas requires protein kinase C-delta.
|
19169273 |
2009 |
Glioma
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Expression of p-Akt and COX-2 in gastric adenocarcinomas and adenovirus mediated Akt1 and COX-2 ShRNA suppresses SGC-7901 gastric adenocarcinoma and U251 glioma cell growth in vitro and in vivo.
|
19925030 |
2009 |
Glioma
|
0.400 |
Biomarker
|
disease |
CTD_human |
The induction of cyclooxygenase-2 (COX-2) expression is associated with more aggressive gliomas and poor survival.
|
15561105 |
2005 |